Category:

Description

Lemtrada (alemtuzumab), Abagovomab,Adecatumumab (MT201),

Lemtrada (alemtuzumab), Abagovomab,Adecatumumab (MT201),  is a humanized monoclonal antibody that is administered daily for 5 days, and then no further therapy is required for 12 months.

make your Quota here

[Contact_Form_Builder id=”6″]

Reviews

There are no reviews yet.

Be the first to review “Lemtrada (alemtuzumab), Abagovomab,Adecatumumab (MT201),”

Your email address will not be published. Required fields are marked *